** Shares of drug distributor Cencora COR.N fall 5.3% to $342.46 premarket

** Co's quarterly revenue of $85.93 billion misses analysts' average expectation of $86.03 billion

** Co reports Q1 adj. profit of $4.08/shr vs analysts' average estimate of $4.04/shr – LSEG data

** Shares were up ~50% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))